MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Dietary and Environmental Risk factors of Parkinson’s Disease: An integrated study combining Network Pharmacology and Molecular Docking Analyses

D. Ghosh, P. Basu, S. Mondal, S. Pal (Kolkata, India)

Meeting: 2025 International Congress

Keywords: Parkinson’s

Category: Artificial Intelligence (AI) and Machine Learning

Objective: This large-scale case-control study using network pharmacology and molecular docking, aimed to identify dietary and environmental risk factors of Parkinson’s disease (PD).

Background: PD is a prevalent neurodegenerative disorder with limited therapeutic options. Environmental influence and dietary variations are well-known risk factors for various diseases including neurodegenerative disorders. Preliminary evidence suggests that diet in early-life and living environment might influence the incidence of Parkinson’s disease (PD) in later phase of life. There have been limited epidemiologic studies on this aspect especially in India.

Method: Patients with PD (n = 200), Alzheimer’s disease (AD) (n = 150) and healthy individuals (n = 200) were recruited. Dietary intake and environmental exposures were assessed using a validated Food-Frequency and Environmental Hazard Questionnaire. Cox regression models were applied to assess the association between dietary intake, environmental factors and mortality risk. Subsequently, network pharmacology approaches (Protein-protein interaction (PPI) network, enrichment analyses) and molecular docking were conducted to predict dietary and environmental targets in PD.

Results: Intake of carbohydrate and fat was significantly higher whereas dietary fiber and fruit content was significantly lesser in PD as compared to AD and healthy age-matched controls. Meat and milk intake was significantly associated with increased mortality risk in PD and AD (p<0.01). Rural living and exercise were significantly associated with decreased mortality risk in PD (p<0.001). Network pharmacology approaches and molecular docking identified key molecular targets and pathways involved in neurodegenerations like PD and AD.

Conclusion: To our understanding, this is one of the pioneering large-scale studies identifying higher intake of certain food groups and effects of certain environmental factors that were associated with mortality risk of PD and AD. Hence, preventive strategies related to dietary and environmental modulators in PD might be clinically useful in the future.

To cite this abstract in AMA style:

D. Ghosh, P. Basu, S. Mondal, S. Pal. Dietary and Environmental Risk factors of Parkinson’s Disease: An integrated study combining Network Pharmacology and Molecular Docking Analyses [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/dietary-and-environmental-risk-factors-of-parkinsons-disease-an-integrated-study-combining-network-pharmacology-and-molecular-docking-analyses/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/dietary-and-environmental-risk-factors-of-parkinsons-disease-an-integrated-study-combining-network-pharmacology-and-molecular-docking-analyses/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley